Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul;96(1147):20220982.
doi: 10.1259/bjr.20220982. Epub 2023 May 15.

Identification of vulnerable carotid plaque with histologically validated CT-derived plaque maps

Affiliations

Identification of vulnerable carotid plaque with histologically validated CT-derived plaque maps

Daniel Rhys Obaid et al. Br J Radiol. 2023 Jul.

Abstract

Objectives: Ruptured carotid plaque causes stroke, but differentiating rupture-prone necrotic core from fibrous tissue with CT is limited by overlap of X-ray attenuation. We investigated the ability of CT-derived plaque maps created from ratios of plaque/contrast attenuation to identify histologically proven vulnerable plaques.

Methods: Seventy patients underwent carotid CT angiography and carotid endarterectomy. A derivation cohort of 20 patients had CT images matched with histology and carotid plaque components attenuation defined. In a validation cohort of 50 patients, CT-derived plaque maps were compared in 43 symptomatic vs 40 asymptomatic carotid plaques and accuracy detecting vulnerable plaques calculated.

Results: In 250 plaque areas co-registered with histology, the median attenuation (HU) of necrotic core 43(26-63), fibrous plaque 127(110-162) and calcified plaque 964 (816-1207) created significantly different ratios of plaque/contrast attenuation. CT-derived plaque maps revealed symptomatic plaques had larger necrotic core than asymptomatic (13.5%(5.9-33.3) vs 7.4%(2.3-14.3), p = 0.004) with large necrotic core predicting symptoms (area under ROC curve 0.68, p = 0.004). Twenty-four of 47 carotid plaques were histologically classified as most vulnerable (Starry-Type VI). Plaque maps revealed Type VI plaques had a greater necrotic core volume than Type IV/V plaques and a necrotic core/fibrous plaque ratio >0.5 distinguished Type VI plaques with sensitivity 75.0% (55.1-88.0) and specificity of 39.1% (22.2-59.2).

Conclusions: Carotid plaque components can be differentiated by CT using a ratio of plaque/contrast attenuation. CT-derived plaque map volumes of necrotic core help distinguished the most vulnerable plaques.

Advances in knowledge: CT-derived plaque maps based on plaque/contrast attenuation may provide new markers of carotid plaque vulnerability.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Co-registration of computed tomography (CT) with histology and attenuation sampling. (a) Eversion carotid endarterectomy sample removed “en-bloc”. (b) Plaque components pre-classified using histology (Ca – calcified plaque, Lu – lumen and NC – necrotic core). (c) Attenuation sampling of luminal contrast distal and proximal to plaque. (d) Co-registered CT cross-sectional image. (e) Attenuation sampling from regions of interest in necrotic core.
Figure 2.
Figure 2.
Curved multiplanar reforms of carotid artery plaque with cross-section level of arrow (inserts) of: (a) Ulcerated plaque, (b) Napkin-ring plaque and (c) Low attenuation plaque.
Figure 3.
Figure 3.
Conventional multiplanar reformat and CT Plaque Map analysis of (a) and (b) predominantly fibrous plaque, (c) and (d) calcified plaque and (E) and (F) necrotic core. With fibrous plaque colored blue, calcified plaque white, necrotic core red and lumen green.
Figure 4.
Figure 4.
Box and whisker plot showing (a) attenuation values of carotid plaque components and (b) plaque/contrast attenuation ratios of carotid plaque components.
Figure 5.
Figure 5.
Receiver operating characteristic curve for necrotic core percentage in symptomatic carotid plaque.

References

    1. Barnett HJM, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, et al. . Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med 1998; 339: 1415–25. doi: 10.1056/NEJM199811123392002 - DOI - PubMed
    1. Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, et al. . Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline for healthcare professionals from the American heart association/American stroke association. Stroke 2014; 45: 2160–2236. doi: 10.1161/STR.0000000000000024 - DOI - PubMed
    1. Eckstein HH. European society for vascular surgery guidelines on the management of atherosclerotic carotid and vertebral artery disease. Eur J Vasc Endovasc Surg 2018; 55: 1–2. doi: 10.1016/j.ejvs.2017.06.026 - DOI - PubMed
    1. Redgrave JNE, Lovett JK, Gallagher PJ, Rothwell PM. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: The Oxford plaque study. Circulation 2006; 113: 2320–28. doi: 10.1161/CIRCULATIONAHA.105.589044 - DOI - PubMed
    1. Huibers A, de Borst GJ, Wan S, Kennedy F, Giannopoulos A, Moll FL, et al. . Non-invasive carotid artery imaging to identify the vulnerable plaque: Current status and future goals. Eur J Vasc Endovasc Surg 2015; 50: 563–72. doi: 10.1016/j.ejvs.2015.06.113 - DOI - PubMed

MeSH terms